Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Memorial Sloan Kettering Cancer Center
Condition: Thyroid Cancer
NCT01025453
Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.